Information from drug sellers on use of misoprostol and what to expect by region and total, Colombia 2017
| Study area | Total | |||||
| Bogotá | Coffee Axis | |||||
| % | n | % | n | % | n | |
| (n=183) | (n=187) | (n=370) | ||||
| Accuracy of dosage instructions* | ||||||
| Below recommended dose (<800 µg) | 4.4 | 8 | 2.1 | 4 | 3.2 | 12 |
| At least minimum recommended dose (≥800 µg) | 39.3 | 72 | 39.6 | 74 | 39.5 | 146 |
| No dosage instructions provided | 56.3 | 103 | 58.3 | 109 | 57.3 | 212 |
| Accuracy of administration route instructions* | ||||||
| Advised optimal routes | 2.7 | 5 | 2.1 | 4 | 2.4 | 9 |
| Advised mixture of optimal and suboptimal routes | 36.1 | 66 | 36.9 | 69 | 36.5 | 135 |
| Advised suboptimal routes | 3.3 | 6 | 3.7 | 7 | 3.5 | −3 |
| No administration instructions provided | 57.9 | 106 | 57.2 | 107 | 57.6 | 213 |
*Accuracy of dosage and routes based on WHO clinical practice guidelines recommended that a minimum of 800 µg of misoprostol (typically four 200 µg pills) should be taken either sublingually, vaginally or buccally. Source: WHO, 2018.9